Quote | Xortx Therapeutics Inc. (TSXVC:XRTX:CC)
Last: | $2.30 |
---|---|
Change Percent: | 6.48% |
Open: | $2.22 |
Close: | $2.30 |
High: | $2.36 |
Low: | $2.17 |
Volume: | 12,565 |
Last Trade Date Time: | 05/06/2022 04:56:49 pm |
News | Xortx Therapeutics Inc. (TSXVC:XRTX:CC)
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
Malibu, CA, United States (ABN Newswire) - In this segment of Money Talk Radio with Ellis Martin, we speak with Dr. Allen Davidoff, CEO of XORTX Therapeutics (NASDAQ:XRTX) (CVE:XRTX), a pioneer in developing new therapies for progressive kidney disease and diabetes. Recently Vertex Pharmaceut...
Message Board Posts | Xortx Therapeutics Inc. (TSXVC:XRTX:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Xortx Therapeutics Inc. Company Name:
XRTX:CC Stock Symbol:
TSXVC Market:
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
Malibu, CA, United States (ABN Newswire) - In this segment of Money Talk Radio with Ellis Martin, we speak with Dr. Allen Davidoff, CEO of XORTX Therapeutics (NASDAQ:XRTX) (CVE:XRTX), a pioneer in developing new therapies for progressive kidney disease and diabetes. Recently Vertex Pharmaceut...
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive...